Skip to content
Unrated Drug recall · FDA · Published May 16, 2018

Ideaz Screamin' Hot Pain Gel Recall: Benzene Overexposure Risk

Ideaz recalls 0.03% capsaicin pain gel due to benzene levels exceeding safe limits in manufacturing. Affected products include 2oz tubes (UPC 7 50263 80072 4) and 5oz tubes (UPC 7 50263 80007 6).

🇺🇸 FDA recall #D-0834-2018DrugIdeaz ›
Take action

Contact the company

Recalling firmIdeaz Llc400 Sproul St · Mc Kees Rocks, PA 15136-2811
✎ GovInfoNow plain-language explainer

What happened, in plain English

Ideaz is recalling their Screamin' Hot pain-relieving gel because it was made with benzene levels above legal limits. This could pose a health risk if the gel is used as intended. Read more at govinfonow.com/recall/40544-ideaz-screamin-hot-pain-gel-recall-benzene-overexposure-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/40544-ideaz-screamin-hot-pain-gel-recall-benzene-overexposure-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0834-2018

Cite this page

“Ideaz Screamin' Hot Pain Gel Recall: Benzene Overexposure Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40544-ideaz-screamin-hot-pain-gel-recall-benzene-overexposure-risk. Based on FDA recall #D-0834-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0834-2018%22&limit=1).

Why it’s dangerous

The gel was manufactured with benzene levels exceeding the legal limits for drug products. Benzene is a known carcinogen that can cause health issues when inhaled or absorbed through the skin.

Who’s affected

People who own or use the Screamin' Hot pain gel products with the listed UPCs and expiration dates are affected. Those with sensitive skin or frequent use may be at higher risk.

How to tell if you have this one

Check for 2oz tubes with UPC 7 50263 80072 4, 5oz tubes with UPC 7 50263 80007 6, or 16oz bottles with UPC 7 50263 80076 2. Products with lot numbers 116002 (exp 01/19), 217003 (exp 02/20), or 1217017 (exp 12/20) are affected.

  • Brand
    Ideaz
  • Product
    screamin' hot (capsaicin) Pain Relieving Gel, 0.03%, packaged in a) 2 OZ (57g) tubes, UPC 7 50263 80072 4; b) 5 oz
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the U.S.A.
Recall numberProduct, codes & lotsQuantity
D-0834-2018screamin' hot (capsaicin) Pain Relieving Gel, 0.03%, packaged in a) 2 OZ (57g) tubes, UPC 7 50263 80072 4; b) 5 oz. (141g) tubes, UPC 7 50263 80007 6; and c) 16 oz. (454g) bottles, UPC 7 50263 80076 2; MFD FOR: Toast Products, 400 Sproul Street, Pittsburgh, PA 15136; NDC 52099-8005.; Lot #: 116002, Exp 01/19; 217003, Exp 02/20; 1217017, Exp 12/20820.125 pounds
D-0835-2018screamin' menthol (menthol) Pain Relieving Gel, 4%, packaged in a) 2 OZ (57g) tubes, UPC 7 50263 80062 5; b) 5 oz. (141g) tubes, UPC 7 50263 80006 9; and c) 16 oz. (454g) bottles, UPC 7 50263 80066 3; MFD FOR: Toast Products, 400 Sproul Street, Pittsburgh, PA 15136; NDC 52099-8010.; Lot #: 1015019, Exp 10/18; 1116011, Exp 11/19800 pounds
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product by UPC or lot number to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: May 16, 201812. FDA classified it Class II: May 24, 201823. Published in FDA’s Enforcement Report: May 30, 201834. FDA terminated the recall: Nov 6, 201842018
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0834-2018 (May 16, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0834-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA